Oncology Research Pharmacy Tech Outpatient

you will assist the Research Pharmacist in all aspects of clinical trial drug management. You will be required to have knowledge of protocol-specific drug information including admixture guidelines, drug stability data as well as drug transport and shipping instructions. You will have a working knowledge of federal regulations related to the use of the investigational drugs as outlined in the Code of Federal Regulations including, but not limited to, documentation guidelines.

You will be responsible for drug inventory and maintaining temperature logs. With Research Pharmacist supervision, you will sign out, prepare and dispense investigational and commercially provided drugs.

The ability to organize daily activities effectively with ability to move from task to task during the dayAt least one year of experience working as a Pharmacy Technician

IV Admixture experience is preferred

Chemotherapy Admixture experience is preferred

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today.

SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please  to learn more about our research offerings.
We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves.

For more information regarding benefits through our parent company, McKesson, please .
As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.
** About Mc Kesson
** We deliver careers with purpose and potential. Our focus on better health starts with creating an inclusive environment with strong values where you can build a fulfilling career. You can count on us to provide you with resources and opportunities to grow and be your best, while contributing to our pursuit of improving lives. Every day, McKesson’s employees deliver products to healthcare providers that make a difference in the care and life of a patient.

We work to distribute medical supplies, bandages, syringes, vials of flu vaccine, and pharmaceutical drugs to help real patients like Jack, an eight-year-old boy battling cancer. We take that job seriously. Together, the work we do is shaping the future of healthcare. If you are passionate about combining a meaningful career with a balanced life, join us on this journey and apply for a job with McKesson today.

Every day, McKesson’s employees deliver products to healthcare providers that make a difference in the care and life of a patient.

By providing your personal information here, you are acknowledging our privacy statement. (English)
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today.

SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please  to learn more about our research offerings.
#J-18808-Ljbffr